192 Additionally, mRNA therapy has been applied to treat patients with deficiencies in essential enzyme genes, such as argininosuccinate lyase, ornithine transcarbamylase, and methylmalonyl-CoA mutase (MUT), therefore restoring enzyme levels and mitigating deficiencies
patients who did not work with a Nourish RD) 64% of Nourish patients reported improvements in side effects like nausea and GI discomfort Nourish patients on GLP-1s reported better adherence (15% missing a dose vs
However, heterogeneity in outcome definitions and reporting complicates interpretation
For T2DM, therapy is often ongoing
But the evidence supports real, clinically meaningful benefits for many people with T1D: less insulin needed each day, flatter post-meal glucose curves visible on your CGM, meaningful weight loss where relevant, and based on emerging data potentially significant long-term protection for the heart and kidneys